Apr 22, 2021

Featuring slide presentations and related discussion from Drs Matthew S Davids and Jennifer Woyach, including the following topics:

• Recent Advances with BTK Inhibitors in the Treatment of CLL — Matthew S Davids, MD, MMSc (0:00)
• Bcl-2 Inhibitors, PI3K Inhibitors and CAR T-Cell Regimens — Jennifer Woyach, MD...

Apr 22, 2021

Featuring perspectives from Drs Matthew S Davids and Jennifer Woyach on the following topics:

• Introduction (0:00)
• Recent advances with BTK inhibitors in the treatment of chronic lymphocytic leukemia (CLL) (1:03)
• Role of Bcl-2 inhibitor-based regimens in therapy for CLL (42:59)
• Novel strategies – U2 regimen...

Apr 21, 2021

Proceedings from part 4 of a 4-part webinar series. Featuring perspectives from Drs Paul M Barr, Matthew S Davids and Kerry Rogers, including the following topics:

• Introduction (0:00)
• Available and emerging data with Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia (CLL) (0:53)
• Role of Bcl-2...

Apr 20, 2021

Featuring slide presentations and related discussion from Drs Arjun Balar, Elisabeth I Heath and Jonathan E Rosenberg, including the following topics:

• Evolving Management of Nonmetastatic Urothelial Bladder Cancer — Arjun Balar, MD (0:00)
• Emerging Data for Treatment of Metastatic Urothelial Carcinoma — Jonathan E...

Apr 20, 2021

Featuring perspectives from Drs Arjun Balar, Elisabeth I Heath and Jonathan E Rosenberg on the following topics:

• Introduction (0:00)
• Case: A woman in her early 60s with Stage IIIA urothelial bladder cancer (UBC) (4:27)
• Case: A woman in her late 60s with cisplatin-ineligible muscle-invasive UBC (8:45)
• Case: A woman in...